5WLV

Carbonic Anhydrase II in complex with aryloxy-2-hydroxypropylammine sulfonamide

Summary for 5WLV

Entry DOI	10.2210/pdb5wlv/pdb
Descriptor	Carbonic anhydrase 2, ZINC ION, 4-{(2R)-2-hydroxy-3-[(propan-2-yl)amino]propoxy}-N-[2-(4-sulfamoylphenyl)ethyl]benzamide, ... (6 entities in total)
Functional Keywords	carbonic anhydrase, beta adrenergic receptor, sulfonamide, aryloxy-2-hydroxypropylammine, lyase, lyase-inhibitor complex, lyase/inhibitor
Biological source	Homo sapiens (Human)
Total number of polymer chains	1
Total formula weight	30039.35
Authors	Lomelino, C.L.,Andring, J.T.,McKenna, R. (deposition date: 2017-07-27, release date: 2018-08-01, Last modification date: 2023-10-04)
Primary citation	Nocentini, A.,Ceruso, M.,Bua, S.,Lomelino, C.L.,Andring, J.T.,McKenna, R.,Lanzi, C.,Sgambellone, S.,Pecori, R.,Matucci, R.,Filippi, L.,Gratteri, P.,Carta, F.,Masini, E.,Selleri, S.,Supuran, C.T. Discovery of beta-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy. J. Med. Chem., 61:5380-5394, 2018 Cited by PubMed: 29851481 DOI: 10.1021/acs.jmedchem.8b00625 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.4 Å)

Structure validation